Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine.
Eur J Cancer. 2017 Oct;84:290-303. doi: 10.1016/j.ejca.2017.07.026. Epub 2017 Aug 29.
Eur J Cancer. 2017.
PMID: 28846956
Review.
Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?
Nebot-Bral L, Coutzac C, Kannouche PL, Chaput N.
Nebot-Bral L, et al.
Bull Cancer. 2019 Feb;106(2):105-113. doi: 10.1016/j.bulcan.2018.08.007. Epub 2018 Oct 17.
Bull Cancer. 2019.
PMID: 30342749
Review.
Item in Clipboard
Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume.
Belkouchi Y, Nebot-Bral L, Lawrance L, Kind M, David C, Ammari S, Cournède PH, Talbot H, Vuagnat P, Smolenschi C, Kannouche PL, Chaput N, Lassau N, Hollebecque A.
Belkouchi Y, et al. Among authors: nebot bral l.
Front Oncol. 2022 Oct 25;12:982790. doi: 10.3389/fonc.2022.982790. eCollection 2022.
Front Oncol. 2022.
PMID: 36387101
Free PMC article.
Item in Clipboard
Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers.
Nebot-Bral L, Hollebecque A, Yurchenko AA, de Forceville L, Danjou M, Jouniaux JM, Rosa RCA, Pouvelle C, Aoufouchi S, Vuagnat P, Smolenschi C, Colomba E, Leary A, Marabelle A, Scoazec JY, Cassard L, Nikolaev S, Chaput N, Kannouche P.
Nebot-Bral L, et al.
J Immunother Cancer. 2022 Jul;10(7):e005059. doi: 10.1136/jitc-2022-005059.
J Immunother Cancer. 2022.
PMID: 35896284
Free PMC article.
Item in Clipboard
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.
Coutzac C, Jouniaux JM, Paci A, Schmidt J, Mallardo D, Seck A, Asvatourian V, Cassard L, Saulnier P, Lacroix L, Woerther PL, Vozy A, Naigeon M, Nebot-Bral L, Desbois M, Simeone E, Mateus C, Boselli L, Grivel J, Soularue E, Lepage P, Carbonnel F, Ascierto PA, Robert C, Chaput N.
Coutzac C, et al. Among authors: nebot bral l.
Nat Commun. 2020 May 1;11(1):2168. doi: 10.1038/s41467-020-16079-x.
Nat Commun. 2020.
PMID: 32358520
Free PMC article.
Item in Clipboard
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.
Auclin E, Vuagnat P, Smolenschi C, Taieb J, Adeva J, Nebot-Bral L, Garcia de Herreros M, Vidal Tocino R, Longo-Muñoz F, El Dakdouki Y, Martín-Romano P, Gaba L, Saurí T, Oliveres H, Castañón E, Garcia-Carbonero R, Besse B, Massard C, Mezquita L, Hollebecque A.
Auclin E, et al. Among authors: nebot bral l.
Cancers (Basel). 2021 Jul 27;13(15):3776. doi: 10.3390/cancers13153776.
Cancers (Basel). 2021.
PMID: 34359675
Free PMC article.
Item in Clipboard
Cite
Cite